Top of this page
Skip navigation, go straight to the content
U.S. Innovation and Partnerships
At UCB, everything we do starts with a simple question: “How will this create value for people living with severe diseases?” To do this, our approach to innovation keeps patients at the center. We use patient insights to inform our science to build solutions to deliver to patients. Innovation is ongoing as we continue to find solutions to meet the unmet needs of patients.
TransCelerate Biopharma Inc.
To support a model of open innovation, UCB is engaged in partnerships and efforts to foster value for patients. For example, to foster and accelerate clinical trials, UCB partners with TransCelerate Biopharma Inc. to engage with industry organizations, patients, and global regulatory authorities on best approaches for adapting research models to include patient-driven solutions and data.
Women of Childbearing Age
A key underserved patient population is women of childbearing age managing chronic conditions. UCB is committed to collaborating with these patients and incorporating their needs in the innovative process. UCB is the industry representative to the National Institutes of Health’s Task Force on Research Specific to Pregnant and Lactating Women.
We are also collaborating with the American Gastroenterological Association to address the lack of easily accessible and accurate information about inflammatory bowel disease for patients of childbearing age.
Solution Accelerator at Georgia Tech
In innovation, sometimes the best ideas come from interactions between experts from different fields. By making a strong commitment to partnering with cutting edge researchers, the Solution Accelerator at Georgia Tech allows us to work together to push the boundaries of modern medicine. In our partnership, UCB researchers are working with Georgia Tech to use machine learning to unlock the match for epilepsy patients by finding the right medicine for the right patient faster.